Heart Rate Variability and Length of Survival in Hospice Cancer Patients

Overview

Journal J Korean Med Sci

Specialty General Medicine

Date 2010 Aug 3

PMID 20676323

Citations 25

Authors

Do Hoon Kim

Jeong A Kim

Youn Seon Choi

Su Hyun Kim

June Young Lee

Young Eun Kim

Affiliations

Soon will be listed here.

Abstract

We examined the association between heart rate variability (HRV) and survival duration to evaluate the usefulness of HRV as a prognostic factor for hospice cancer patients. In terminally ill cancer patients who visited the Hospice clinic, we checked demographic data, Karnofsky performance scale (KPS), HRV, dyspnea, anorexia, as well as fasting blood glucose and total cholesterol. After following up their duration of survival, we examined meaningful prognostic factors for predicting life expectancy through the survival analysis. A total of 68 patients were included in final analysis. As KPS was lower, or when combined with dyspnea or anorexia, the survival duration was much shorter. HRV parameters except heart rate were all impaired in most patients. In particular, the group with mean heart rate of 100 or more beats per minute and the group with standard deviations of normal-to-normal R-R intervals (SDNN) of 21.3 ms (75 percentile) or less showed significantly shorter survival duration. The final multivariate analysis adjusting for age, gender, fasting blood glucose, and total cholesterol showed that KPS, dyspnea, anorexia, and SDNN were significant prognostic factors in survival duration. For the first time, we report that SDNN is a prognostic factor in terminal cancer patients.

Citing Articles

Impact of anxiety and chemotherapy side effects on quality of life in patients with malignant lymphoma.

Teshigawara Y, Tanaka K, Tachi T, Shishido M, Inoue S, Makino T Support Care Cancer. 2025; 33(3):238.

PMID: 40019579 DOI: 10.1007/s00520-025-09294-z.

The Validity of Apple Watch Series 9 and Ultra 2 for Serial Measurements of Heart Rate Variability and Resting Heart Rate.

OGrady B, Lambe R, Baldwin M, Acheson T, Doherty C Sensors (Basel). 2024; 24(19).

PMID: 39409260 PMC: 11478500. DOI: 10.3390/s24196220.

How to properly evaluate cardiac vagal tone in oncology studies: a state-of-the-art review.

Martinez P, Grinand M, Cheggour S, Taieb J, Gourjon G J Natl Cancer Cent. 2024; 4(1):36-46.

PMID: 39036385 PMC: 11256691. DOI: 10.1016/j.jncc.2024.02.002.

Changepoint Detection in Heart Rate Variability Indices in Older Patients Without Cancer at End of Life Using Ballistocardiography Signals: Preliminary Retrospective Study.

Yanagisawa N, Nishizaki Y, Yao B, Zhang J, Kasai T JMIR Form Res. 2024; 8:e53453.

PMID: 38345857 PMC: 10897814. DOI: 10.2196/53453.

Evaluation of Anorexia in Cancer and Its Association with Autonomic Nervous System Activity Assessed by Heart Rate Variability.

Molfino A, Gallicchio C, Imbimbo G, Melena M, Antonini S, Gigante A Nutrients. 2023; 15(23).

PMID: 38068794 PMC: 10707971. DOI: 10.3390/nu15234936.

References

Min K, Min J, Paek D, Cho S . The impact of the components of metabolic syndrome on heart rate variability: using the NCEP-ATP III and IDF definitions. Pacing Clin Electrophysiol. 2008; 31(5):584-91. DOI: 10.1111/j.1540-8159.2008.01045.x. View

Molgaard H, Sorensen K, Bjerregaard P . Attenuated 24-h heart rate variability in apparently healthy subjects, subsequently suffering sudden cardiac death. Clin Auton Res. 1991; 1(3):233-7. DOI: 10.1007/BF01824992. View

Pyenson B, Connor S, Fitch K, Kinzbrunner B . Medicare cost in matched hospice and non-hospice cohorts. J Pain Symptom Manage. 2004; 28(3):200-10. DOI: 10.1016/j.jpainsymman.2004.05.003. View

Christensen J, Toft E, Christensen M, Schmidt E . Heart rate variability and plasma lipids in men with and without ischaemic heart disease. Atherosclerosis. 1999; 145(1):181-6. DOI: 10.1016/s0021-9150(99)00052-0. View

Bilchick K, Fetics B, Djoukeng R, Fisher S, Fletcher R, Singh S . Prognostic value of heart rate variability in chronic congestive heart failure (Veterans Affairs' Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure). Am J Cardiol. 2002; 90(1):24-8. DOI: 10.1016/s0002-9149(02)02380-9. View

Pirovano M, Maltoni M, Nanni O, Marinari M, Indelli M, Zaninetta G . A new palliative prognostic score: a first step for the staging of terminally ill cancer patients. Italian Multicenter and Study Group on Palliative Care. J Pain Symptom Manage. 1999; 17(4):231-9. DOI: 10.1016/s0885-3924(98)00145-6. View

Risk M, Bril V, Broadbridge C, Cohen A . Heart rate variability measurement in diabetic neuropathy: review of methods. Diabetes Technol Ther. 2001; 3(1):63-76. DOI: 10.1089/152091501750220028. View

Stein P, Barzilay J, Domitrovich P, Chaves P, Gottdiener J, Heckbert S . The relationship of heart rate and heart rate variability to non-diabetic fasting glucose levels and the metabolic syndrome: the Cardiovascular Health Study. Diabet Med. 2007; 24(8):855-63. DOI: 10.1111/j.1464-5491.2007.02163.x. View

Keam B, Oh D, Lee S, Kim D, Kim M, Im S . Aggressiveness of cancer-care near the end-of-life in Korea. Jpn J Clin Oncol. 2008; 38(5):381-6. DOI: 10.1093/jjco/hyn031. View

10.

Lamont E, Christakis N . Complexities in prognostication in advanced cancer: "to help them live their lives the way they want to". JAMA. 2003; 290(1):98-104. DOI: 10.1001/jama.290.1.98. View

11.

Mor V, Kidder D . Cost savings in hospice: final results of the National Hospice Study. Health Serv Res. 1985; 20(4):407-22. PMC: 1068891. View

12.

Kidder D . The effects of hospice coverage on Medicare expenditures. Health Serv Res. 1992; 27(2):195-217. PMC: 1069873. View

13.

de Miguel Sanchez C, Garrido Elustondo S, Estirado A, Sanchez F, de La Rasilla Cooper C, Romero A . Palliative performance status, heart rate and respiratory rate as predictive factors of survival time in terminally ill cancer patients. J Pain Symptom Manage. 2006; 31(6):485-92. DOI: 10.1016/j.jpainsymman.2005.10.007. View

14.

. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Eur Heart J. 1996; 17(3):354-81. View

15.

Kikuya M, Hozawa A, Ohokubo T, Tsuji I, Michimata M, Matsubara M . Prognostic significance of blood pressure and heart rate variabilities: the Ohasama study. Hypertension. 2000; 36(5):901-6. DOI: 10.1161/01.hyp.36.5.901. View

16.

Laederach-Hofmann K, Mussgay L, Winter A, Klinkenberg N, Ruddel H . Early autonomic dysfunction in patients with diabetes mellitus assessed by spectral analysis of heart rate and blood pressure variability. Clin Physiol. 1999; 19(2):97-106. DOI: 10.1046/j.1365-2281.1999.00150.x. View

17.

Fukuta H, Hayano J, Ishihara S, Sakata S, Mukai S, Ohte N . Prognostic value of heart rate variability in patients with end-stage renal disease on chronic haemodialysis. Nephrol Dial Transplant. 2003; 18(2):318-25. DOI: 10.1093/ndt/18.2.318. View

18.

Park S, Lee B, Jeong K . Standardized tests of heart rate variability for autonomic function tests in healthy Koreans. Int J Neurosci. 2007; 117(12):1707-17. DOI: 10.1080/00207450601050097. View

19.

Reyners A, Hazenberg B, Reitsma W, Smit A . Heart rate variability as a predictor of mortality in patients with AA and AL amyloidosis. Eur Heart J. 2002; 23(2):157-61. DOI: 10.1053/euhj.2001.2972. View

20.

DANEV S, Nikolova R, Kerekovska M, Svetoslavov S . Relationship between heart rate variability and hypercholesterolaemia. Cent Eur J Public Health. 1997; 5(3):143-6. View